アレルギー診断薬市場：製品・サービス別（消耗品、機器（免疫測定装置、ELISA分析装置、ルミノメーター）、サービス）、アレルゲン（食物、吸入、薬物）、検査タイプ（In Vivo、In Vitro）、エンドユーザー（診断研究所） - 2026年までの世界予測

Allergy Diagnostics Market by Product & Service (Consumables, Instruments (Immunoassay Analyzer, ELISA Analyzer, Luminometer), Service), Allergen (Food, Inhaled, Drug), Test Type (In Vivo, In Vitro), End User (Diagnostic Laboratories) - Global Forecast to 2026

世界のアレルギー診断市場は、2021年の48億米ドルから2026年には82億米ドルになると予測されており、2021年から2026年にかけて11.1%のCAGRで推移しています。この市場の成長は、アレルギー疾患の発生率の高さ... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2021年8月31日	US$4,950 シングルユーザライセンスライセンス・価格情報注文方法はこちら	288	404	英語

下記、日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

世界のアレルギー診断市場は、2021年の48億米ドルから2026年には82億米ドルになると予測されており、2021年から2026年にかけて11.1%のCAGRで推移しています。この市場の成長は、アレルギー疾患の発生率の高さとそれに伴う経済的負担の大きさ、環境汚染レベルの上昇、アレルギー診断に対する組織の資金提供の増加、医療保険へのアクセスの増加などが要因となっています。また、アレルギー診断におけるmHealthの利用は、予測期間中の市場成長の機会となることが予想されます。

"2021年の製品・サービス別アレルギー診断市場では、消耗品が最大のシェアを占めると予想されています。"

アレルギー診断市場は、製品・サービス別に、消耗品、機器、サービスに分けられます。2020年のアレルギー診断市場では、消耗品分野が最大のシェアを占めています。消耗品セグメントの大きなシェアは、アレルギー患者の増加と、アレルギー症状を診断するための迅速な検査の必要性に起因しています。また、消耗品分野は、予測期間中に大きな成長が見込まれています。

"2021年の検査タイプ別アレルギー診断市場では、in vivo検査が最大のシェアを占めると予想されています。"

検査タイプに基づいて、アレルギー診断市場はin vivoテストとin vitroテストに分けられます。2020年のアレルギー診断市場では、in vivoテストのセグメントが最大のシェアを占めています。このセグメントの成長は、主に皮膚プリックテストなどの様々なin vivoテストの採用が増えていることによります。これらの検査は、in vitro検査と比較して、信頼性、安全性、利便性が高く、費用対効果に優れています。

"2021年のアレルギー診断市場では、吸入アレルゲンがアレルゲン別で最大のシェアを占めることが予想されます。"

アレルギー診断市場は、アレルゲンに基づき、吸入アレルゲン、食物アレルゲン、薬物アレルゲン、その他のアレルゲンに分類されます。2020年には、環境汚染の増加や花粉の増加に加えて、カビ、カビ、ホコリなどの要因も相まって、吸入アレルゲン分野がアレルギー診断市場で最大のシェアを占めました。

"2021年のエンドユーザー別アレルギー診断市場では、診断ラボが最大のシェアを占めると予想されています。"

アレルギー診断市場は、エンドユーザーに基づいて、診断ラボ、病院ベースのラボ、学術研究機関、その他のエンドユーザーに分類されます。2020年には、診断ラボ分野が最大のシェアを占めています。これは、専門家による適切な診断が求められていること、アレルギー疾患の管理に対する意識が高まっていること、独立した診断ラボの運営に資金が投入されていることなどが主な要因と考えられます。

"2021年のアレルギー診断市場では、北米が最大のシェアを占めています。"

アレルギー診断市場は、地域別に、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカに分けられます。2020年のアレルギー診断市場では、北米が最大のシェアを占めています。北米のシェアが高いのは、アレルギーの発生率が上昇していること、アレルギー診断に対する償還シナリオが良好であること、協会による支援活動が可能であることなどが要因として挙げられます。

サプライサイドの一次インタビューの内訳は、企業タイプ別、呼称別、地域別。

- 企業タイプ別企業タイプ別：ティア1(20%)、ティア2(45%)、ティア3(35%)

- 呼称別 Cレベルエグゼクティブ(30%)、ディレクター(20%)、その他(50%)

- 地域別地域別：北米（30％）、欧州（25％）、アジア太平洋（22％）、中東・アフリカ（13％）、ラテンアメリカ（10

この市場に参入している主な企業は、Thermo Fisher Scientific, Inc（米国）、Danaher（米国）、Minaris Medical America, Inc. (米国)、Siemens Healthineers AG(米国)、Eurofins Scientific(ルクセンブルグ)などがあります。

レポートに掲載されている企業一覧

- サーモフィッシャーサイエンティフィック社（米国

- シーメンス・ヘルシネアーズ（ドイツ

- ダナハー（米国

- オメガ・ダイアグノスティックス・グループPLC（英国

- bioMérieux SA（フランス

- ローマーラボ事業部ホールディング（オーストリア

- EUROIMMUN Medizinische Labordiagnostika AG (ドイツ)

- HollisterStier Allergy（米国

- NEOGEN Corporation (米国)

- ユーロフィンス・サイエンティフィック（ルクセンブルグ

- Minaris Medical America, Inc. (米国)

- Stallergenes Greer (英国)

- HOB Biotech Group Corp, Ltd. (中国) (中国)

- HYCOR Biomedical（米国

- R-Biopharm AG（ドイツ

- AESKU.GROUP GmbH（ドイツ

- ACON Laboratories, Inc. (米国)

- Lincoln Diagnostics, Inc. (米国)

- Astra Biotech GmbH（ドイツ

- エルバ・グループ（英国

ページTOPに戻る

Summary

The global allergy diagnostics market is projected to USD 8.2 billion by 2026 from USD 4.8 billion in 2021, at a CAGR of 11.1% from 2021 to 2026. The growth of this market is driven owing to the high incidence of allergic diseases and associated heavy economical burden, rising environmental pollution levels, increasing funds by organizations in allergy diagnostics, and the increasing access to healthcare insurance. Also, use of mHealth in allergy diagnosis is anticipated to offer an opportunity for the growth of the market during the forecast period.

“Consumables are expected to hold the largest share of the allergy diagnostics market, by product & service in 2021.”
Based on product & service, the allergy diagnostics market is segmented into consumables, instruments, and services. In 2020, the consumables segment accounted for the largest share of the allergy diagnostics market. The large share of the consumables segment can be attributed to the increasing cases of allergies and the need for rapid tests to diagnose allergic conditions. The consumables segment is also expected to witness significant growth during the forecast period.

“In vivo tests are expected to hold the largest share of the allergy diagnostics market, by test type in 2021.”
Based on test type, the allergy diagnostics market is segmented into in vivo tests and in vitro tests. In 2020, the in vivo tests segment accounted for the largest share of the allergy diagnostics market. The growth of this segment is mainly driven by the increasing adoption of various in vivo tests, such as skin prick tests. These tests are dependable, safe, convenient, and cost-effective, as compared to in vitro tests.
“Inhaled allergens are expected to hold the largest share of the allergy diagnostics market, by allergen in 2021.”
Based on allergens, the allergy diagnostics market is segmented into inhaled allergens, food allergens, drug allergens, and other allergens. In 2020, the inhaled allergens segment accounted for the largest share of the allergy diagnostics market due to the increasing environmental pollution and rising pollen coupled with other factors such as fungus, mold, and dust.
“Diagnostic laboratories are expected to hold the largest share of the allergy diagnostics market, by end user in 2021.”
Based on end user, the allergy diagnostics market is segmented into diagnostic laboratories, hospital-based laboratories, academic research institutes, and other end users. In 2020, the diagnostic laboratories segment accounted for the largest share of the market. The large share of the segment can be primarily attributed to the preference for proper diagnosis from a specialist, rising awareness regarding the management of allergic diseases, and the availability of funds for the operation of independent diagnostic laboratories.

“North America commanded the largest share of the allergy diagnostics market in 2021.”

Based on region, the allergy diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America commanded the largest share of the allergy diagnostics market. The large share of North America can be attributed to the rising incidence of allergies, favorable reimbursement scenarios for allergy diagnosis, and the availability of supportive initiatives by associations.

Breakdown of supply-side primary interviews, by company type, designation, and region:

• By Company Type: Tier 1 (20%) , Tier 2 (45%), and Tier 3 (35%)
• By Designation: C-level Executives (30%), Directors (20%), and Others (50%)
• By Region: North America (30%), Europe (25%), AsiaPacific (22%), Middle East & Africa (13%), and Latin America (10%)

Some of the major players operating in this market are Thermo Fisher Scientific, Inc (US), Danaher (US), Minaris Medical America, Inc. (US), Siemens Healthineers AG (US), and Eurofins Scientific (Luxembourg)

List of Companies Profiled in the Report
• Thermo Fisher Scientific Inc., (US)
• Siemens Healthineers (Germany)
• Danaher (US)
• Omega Diagnostics Group PLC (UK)
• bioMérieux SA (France)
• Romer Labs Division Holding (Austria)
• EUROIMMUN Medizinische Labordiagnostika AG (Germany)
• HollisterStier Allergy (US)
• NEOGEN Corporation (US)
• Eurofins Scientific (Luxembourg)
• Minaris Medical America, Inc. (US)
• Stallergenes Greer (UK)
• HOB Biotech Group Corp., Ltd. (China)
• HYCOR Biomedical (US)
• R-Biopharm AG (Germany)
• AESKU.GROUP GmbH (Germany)
• ACON Laboratories, Inc. (US)
• Lincoln Diagnostics, Inc. (US)
• Astra Biotech GmbH (Germany)
• Erba Group (UK)
Research Coverage
This report studies the allergy diagnostics market based on product & service, allergen, test type, end user, and region. The report also analyzes factors (such as drivers, restraints, trends, opportunities, and challenges) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total allergy diagnostics market. The report forecasts the revenue of the market segments with respect to five major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on allergy diagnostics offered by the top 20 players in the allergy diagnostics market. The report analyzes the allergy diagnostics market product & service, allergen, test type, end user, and region.

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devices across key geographic regions.

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the allergy diagnostics market

• Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the allergy diagnostics market

ページTOPに戻る

1 INTRODUCTION 42
1.1 OBJECTIVES OF THE STUDY 42
1.2 MARKET DEFINITION 42
1.2.1 INCLUSIONS AND EXCLUSIONS OF THE STUDY 43
1.3 MARKET SCOPE 44
1.3.1 MARKET SEGMENTATION 44
1.3.2 YEARS CONSIDERED FOR THE STUDY 45
1.4 CURRENCY 45
1.5 LIMITATIONS 45
1.6 MARKET STAKEHOLDERS 46
1.7 SUMMARY OF CHANGES 46
2 RESEARCH METHODOLOGY 47
2.1 RESEARCH DATA 47
FIGURE 1 RESEARCH DESIGN 47
2.1.1 SECONDARY DATA 48
2.1.1.1 Key data from secondary sources 49
2.1.2 PRIMARY DATA 49
FIGURE 2 PRIMARY SOURCES 49
2.1.2.1 Key data from primary sources 50
2.1.2.2 Key industry insights 51
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 51
2.2 MARKET SIZE ESTIMATION 52
FIGURE 4 BOTTOM-UP APPROACH 52
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 53
FIGURE 6 TOP-DOWN APPROACH 54
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 55
FIGURE 7 DATA TRIANGULATION METHODOLOGY 55
2.4 MARKET SHARE ANALYSIS 56
2.5 ASSUMPTIONS FOR THE STUDY 56
2.6 RISK ASSESSMENT/FACTOR ANALYSIS 57
TABLE 1 RISKS 57
2.7 COVID-19 ECONOMIC ASSESSMENT 57
2.8 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 57
FIGURE 8 CRITERIA IMPACTING THE GLOBAL ECONOMY 58
FIGURE 9 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 59

3 EXECUTIVE SUMMARY 60
FIGURE 10 ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2021 VS. 2026 (USD BILLION) 60
FIGURE 11 ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2021 VS. 2026 (USD BILLION) 61
FIGURE 12 ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2021 VS. 2026 (USD BILLION) 62
FIGURE 13 ALLERGY DIAGNOSTICS MARKET, BY END USER,
2021 VS. 2026 (USD BILLION) 63
FIGURE 14 ALLERGY DIAGNOSTICS MARKET, BY REGION, 2021 VS. 2026 (USD BILLION) 64
4 PREMIUM INSIGHTS 65
4.1 ALLERGY DIAGNOSTICS MARKET OVERVIEW 65
FIGURE 15 THE RISING INCIDENCE AND HEAVY ECONOMIC BURDEN OF ALLERGIES IS A KEY FACTOR DRIVING THE MARKET GROWTH 65
4.2 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET SHARE, BY ALLERGEN (2020) 66
FIGURE 16 THE INHALED ALLERGEN SEGMENT DOMINATED THE MARKET IN 2020 66
4.3 GEOGRAPHICAL SNAPSHOT OF THE ALLERGY DIAGNOSTICS MARKET 67
FIGURE 17 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 67
5 MARKET OVERVIEW 68
5.1 INTRODUCTION 68
5.2 MARKET DYNAMICS 68
FIGURE 18 ALLERGY DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND TRENDS 68
5.2.1 DRIVERS 69
5.2.1.1 The high incidence and heavy economic burden of allergic diseases 69
5.2.1.2 Rising environmental pollution levels 69
5.2.1.3 Increasing funding initiatives in allergy diagnostics 70
5.2.1.4 Growing access to health insurance 71
5.2.2 RESTRAINTS 71
5.2.2.1 Premium costs associated with allergy diagnostic instruments 71
5.2.2.2 Limited awareness and poor implementation of allergy testing methods 72
5.2.3 OPPORTUNITIES 72
5.2.3.1 Use of mHealth in allergy diagnosis 72
5.2.4 CHALLENGES 73
5.2.4.1 Shortage of allergists 73
5.2.5 TRENDS 73
5.2.5.1 Reagent rental agreements 73
5.3 SUPPLY CHAIN ANALYSIS 73
FIGURE 19 DIRECT DISTRIBUTION, THE PREFERRED STRATEGY FOR PROMINENT COMPANIES 74

5.4 VALUE CHAIN ANALYSIS 74
FIGURE 20 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES 75
5.5 ECOSYSTEM ANALYSIS OF THE ALLERGY DIAGNOSTICS MARKET 76
FIGURE 21 ECOSYSTEM ANALYSIS OF THE ALLERGY DIAGNOSTICS MARKET 76
5.5.1 ROLE IN THE ECOSYSTEM 76
FIGURE 22 KEY PLAYERS IN THE ALLERGY DIAGNOSTICS MARKET ECOSYSTEM 77
5.6 PRICING ANALYSIS 77
TABLE 2 AVERAGE SELLING PRICES OF ALLERGY DIAGNOSTICS PRODUCTS 77
5.7 REGULATORY OVERVIEW 78
5.7.1 US 78
TABLE 3 US: CLASSIFICATION OF IMMUNOASSAY PRODUCTS 78
FIGURE 23 US: REGULATORY PROCESS FOR IVD DEVICES 79
5.7.2 CANADA 80
FIGURE 24 CANADA: REGULATORY PROCESS FOR IVD DEVICES IN CANADA 80
5.7.3 EUROPE 81
TABLE 4 EUROPE: CLASSIFICATION OF IVD DEVICES 81
5.7.3.1 Europe: regulatory process for IVD devices 82
5.7.4 JAPAN 83
5.7.4.1 Japan: regulatory process for IVD devices 83
TABLE 5 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 84
5.7.5 CHINA 84
TABLE 6 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 84
5.7.6 INDIA 84
5.7.6.1 India: regulatory process for IVD devices 85
5.7.7 INDONESIA 85
TABLE 7 INDONESIA: REGISTRATION PROCESS FOR IVD DEVICES 86
5.7.8 RUSSIA 86
TABLE 8 RUSSIA: CLASSIFICATION OF IVD DEVICES 86
5.7.9 SAUDI ARABIA 87
TABLE 9 SAUDI ARABIA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 87
5.7.10 MEXICO 87
5.7.10.1 Mexico: regulatory process for IVD devices 87
TABLE 10 MEXICO: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 88
5.7.11 BRAZIL 88
5.7.11.1 Brazil: regulatory process for IVD devices 89
5.7.12 SOUTH KOREA 89
TABLE 11 SOUTH KOREA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 89
5.8 TRADE ANALYSIS 90
5.8.1 IMPORT DATA FOR HS CODE 902750, BY COUNTRY,
2016–2020 (USD THOUSAND) 90
5.8.2 EXPORT DATA FOR HS CODE 902750, BY COUNTRY,
2017–2019 (USD THOUSAND) 91
5.8.3 EXPORT DATA FOR HS CODE 902750, BY COUNTRY, 2016–2020 91
5.8.4 IMPORT DATA FOR HS CODE 902750, BY COUNTRY, 2016–2020 92
5.9 PATENT ANALYSIS 92
5.9.1 PATENT ANALYSIS: LUMINOMETERS 92
5.10 TECHNOLOGY ANALYSIS 93
5.11 PORTER’S FIVE FORCES ANALYSIS 93
TABLE 12 HIGH CONSOLIDATION IN THE MARKET TO RESTRICT THE ENTRY OF NEW PLAYERS 93
5.11.1 DEGREE OF COMPETITION 94
5.11.2 BARGAINING POWER OF SUPPLIERS 94
5.11.3 BARGAINING POWER OF BUYERS 94
5.11.4 THREAT OF SUBSTITUTES 94
5.11.5 THREAT OF NEW ENTRANTS 94
5.12 COVID-19 IMPACT ANALYSIS FOR THE ALLERGY DIAGNOSTICS MARKET 94
5.13 RANGES/ SCENARIOS 95
5.13.1 ALLERGY DIAGNOSTICS MARKET FORECAST 95
FIGURE 25 REALISTIC SCENARIO OF THE ALLERGY DIAGNOSTICS MARKET 95
FIGURE 26 PESSIMISTIC SCENARIO OF THE ALLERGY DIAGNOSTICS MARKET 96
FIGURE 27 OPTIMISTIC SCENARIO OF THE ALLERGY DIAGNOSTICS MARKET 96
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESSES 97
5.14.1 REVENUE SHIFT & REVENUE POCKETS FOR ALLERGY DIAGNOSTICS MANUFACTURERS 97
FIGURE 28 REVENUE SHIFT FOR ALLERGY DIAGNOSTICS MARKET 97
6 ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE 98
6.1 INTRODUCTION 99
TABLE 13 ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 99
TABLE 14 ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2020–2026 (USD MILLION) 99
6.2 CONSUMABLES 100
6.2.1 CONSUMABLES ARE THE MOST WIDELY USED PRODUCTS FOR ALLERGY TESTING 100
TABLE 15 ALLERGY DIAGNOSTICS CONSUMABLES MARKET, BY REGION,
2016–2019 (USD MILLION) 101
TABLE 16 ALLERGY DIAGNOSTICS CONSUMABLES MARKET, BY REGION,
2020–2026 (USD MILLION) 101
6.3 INSTRUMENTS 101
TABLE 17 ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 102
TABLE 18 ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 102
TABLE 19 ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY REGION,
2016–2019 (USD MILLION) 103
TABLE 20 ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY REGION,
2020–2026 (USD MILLION) 103
6.3.1 IMMUNOASSAY ANALYZERS 103
6.3.1.1 Immunoassay analyzers are highly preferred for allergy diagnostics 103
TABLE 21 ALLERGY DIAGNOSTICS FOR IMMUNOASSAY ANALYZERS MARKET,
BY REGION, 2016–2019 (USD MILLION) 104
TABLE 22 ALLERGY DIAGNOSTICS FOR IMMUNOASSAY ANALYZERS MARKET,
BY REGION, 2020–2026 (USD MILLION) 104
6.3.2 ELISA ANALYZERS 105
6.3.2.1 The precision offered by ELISA tests to propel the growth of the segment 105
TABLE 23 ALLERGY DIAGNOSTICS FOR ELISA ANALYZERS MARKET, BY REGION,
2016–2019 (USD MILLION) 105
TABLE 24 ALLERGY DIAGNOSTICS FOR ELISA ANALYZERS MARKET, BY REGION,
2020–2026 (USD MILLION) 106
6.3.3 LUMINOMETERS 106
6.3.3.1 Luminometers are convenient to use, thus leading to their increased adoption 106
TABLE 25 ALLERGY DIAGNOSTICS FOR LUMINOMETERS MARKET, BY REGION,
2016–2019 (USD MILLION) 107
TABLE 26 ALLERGY DIAGNOSTICS FOR LUMINOMETERS MARKET, BY REGION,
2020–2026 (USD MILLION) 107
6.3.4 OTHER INSTRUMENTS 107
TABLE 27 ALLERGY DIAGNOSTICS FOR OTHER INSTRUMENTS MARKET, BY REGION, 2016–2019 (USD MILLION) 108
TABLE 28 ALLERGY DIAGNOSTICS FOR OTHER INSTRUMENTS MARKET, BY REGION, 2020–2026 (USD MILLION) 108
6.4 SERVICES 109
6.4.1 RISING CASES OF ALLERGIES TO DRIVE THE GROWTH OF THE SERVICES SEGMENT 109
TABLE 29 ALLERGY DIAGNOSTICS SERVICES MARKET, BY REGION,
2016–2019 (USD MILLION) 109
TABLE 30 ALLERGY DIAGNOSTICS SERVICES MARKET, BY REGION,
2020–2026 (USD MILLION) 109
7 ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE 110
7.1 INTRODUCTION 111
TABLE 31 ALLERGY TESTS ADVANTAGES AND LIMITATIONS 111
TABLE 32 ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION) 111
TABLE 33 ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION) 112
7.2 IN VIVO TESTS 112
TABLE 34 IN VIVO TESTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 112
TABLE 35 IN VIVO TESTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 112
TABLE 36 IN VIVO TESTS MARKET, BY REGION, 2016–2019 (USD MILLION) 113
TABLE 37 IN VIVO TESTS MARKET, BY REGION, 2020–2026 (USD MILLION) 113
7.2.1 SKIN PRICK TESTS 113
7.2.1.1 Skin prick tests are the most widely preferred in vivo allergy tests 113
TABLE 38 SKIN PRICK TESTS MARKET, BY REGION, 2016–2019 (USD MILLION) 114
TABLE 39 SKIN PRICK TESTS MARKET, BY REGION, 2020–2026 (USD MILLION) 114
7.2.2 PATCH TESTS 115
7.2.2.1 Patch tests help in the diagnosis of contact dermatitis, unlike the skin prick test 115
TABLE 40 PATCH TESTS MARKET, BY REGION, 2016–2019 (USD MILLION) 115
TABLE 41 PATCH TESTS MARKET, BY REGION, 2020–2026 (USD MILLION) 115
7.2.3 OTHER IN VIVO TESTS 116
TABLE 42 OTHER IN VIVO TESTS MARKET, BY REGION, 2016–2019 (USD MILLION) 116
TABLE 43 OTHER IN VIVO TESTS MARKET, BY REGION, 2020–2026 (USD MILLION) 117
7.3 IN VITRO TESTS 117
7.3.1 IN VITRO ALLERGY TESTS ARE SET TO WITNESS SIGNIFICANT GROWTH DURING THE FORECAST PERIOD 117
TABLE 44 IN VITRO TESTS MARKET, BY REGION, 2016–2019 (USD MILLION) 118
TABLE 45 IN VITRO TESTS MARKET, BY REGION, 2020–2026 (USD MILLION) 118
8 ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN 119
8.1 INTRODUCTION 120
TABLE 46 ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2016–2019 (USD MILLION) 120
TABLE 47 ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2020–2026 (USD MILLION) 120
8.2 INHALED ALLERGENS 121
8.2.1 INHALED ALLERGENS DOMINATED THE MARKET IN 2020 121
TABLE 48 INHALED ALLERGENS MARKET, BY REGION, 2016–2019 (USD MILLION) 121
TABLE 49 INHALED ALLERGENS MARKET, BY REGION, 2020–2026 (USD MILLION) 122
8.3 FOOD ALLERGENS 122
8.3.1 FOOD ALLERGY IS FOUND TO BE MORE PREVALENT AMONG CHILDREN 122
TABLE 50 SPECIFIC FOOD-INDUCED ALLERGIC CONDITIONS 123
TABLE 51 FOOD ALLERGENS MARKET, BY REGION, 2016–2019 (USD MILLION) 123
TABLE 52 FOOD ALLERGENS MARKET, BY REGION, 2020–2026 (USD MILLION) 124
8.4 DRUG ALLERGENS 124
8.4.1 THE DRUG ALLERGY SEGMENT IS EXPECTED TO WITNESS CONSIDERABLE GROWTH DURING THE FORECAST PERIOD 124
TABLE 53 DRUG ALLERGENS MARKET, BY REGION, 2016–2019 (USD MILLION) 125
TABLE 54 DRUG ALLERGENS MARKET, BY REGION, 2020–2026 (USD MILLION) 125
8.5 OTHER ALLERGENS 125
TABLE 55 OTHER ALLERGENS MARKET, BY REGION, 2016–2019 (USD MILLION) 126
TABLE 56 OTHER ALLERGENS MARKET, BY REGION, 2020–2026 (USD MILLION) 126

9 ALLERGY DIAGNOSTICS MARKET, BY END USER 127
9.1 INTRODUCTION 128
TABLE 57 ALLERGY DIAGNOSTICS MARKET, BY END USER, 2016–2019 (USD MILLION) 128
TABLE 58 ALLERGY DIAGNOSTICS MARKET, BY END USER, 2020–2026 (USD MILLION) 128
9.2 DIAGNOSTIC LABORATORIES 129
9.2.1 DIAGNOSTIC LABORATORIES ACCOUNTED FOR THE LARGEST SHARE OF THE END-USER MARKET IN 2020 129
TABLE 59 ALLERGY DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES,
BY REGION, 2016–2019 (USD MILLION) 129
TABLE 60 ALLERGY DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES,
BY REGION, 2020–2026 (USD MILLION) 130
9.3 HOSPITAL-BASED LABORATORIES 130
9.3.1 HOSPITAL-BASED LABORATORIES ARE MORE ACCESSIBLE TO PATIENTS AND OFFER RAPID RESULTS 130
TABLE 61 ALLERGY DIAGNOSTICS MARKET FOR HOSPITAL-BASED LABORATORIES,
BY REGION, 2016–2019 (USD MILLION) 131
TABLE 62 ALLERGY DIAGNOSTICS MARKET FOR HOSPITAL-BASED LABORATORIES,
BY REGION, 2020–2026 (USD MILLION) 131
9.4 ACADEMIC RESEARCH INSTITUTES 131
9.4.1 GRANTS OFFERED BY ORGANIZATIONS TO SUPPORT THE GROWTH OF THIS SEGMENT 131
TABLE 63 ALLERGY DIAGNOSTICS MARKET FOR ACADEMIC RESEARCH INSTITUTES,
BY REGION, 2016–2019 (USD MILLION) 132
TABLE 64 ALLERGY DIAGNOSTICS MARKET FOR ACADEMIC RESEARCH INSTITUTES,
BY REGION, 2020–2026 (USD MILLION) 133
9.5 OTHER END USERS 133
TABLE 65 ALLERGY DIAGNOSTICS MARKET FOR OTHER END USERS, BY REGION,
2016–2019 (USD MILLION) 134
TABLE 66 ALLERGY DIAGNOSTICS MARKET FOR OTHER END USERS, BY REGION,
2020–2026 (USD MILLION) 134
10 ALLERGY DIAGNOSTICS MARKET, BY REGION 135
10.1 INTRODUCTION 136
TABLE 67 ALLERGY DIAGNOSTICS MARKET, BY REGION, 2016–2019 (USD MILLION) 136
TABLE 68 ALLERGY DIAGNOSTICS MARKET, BY REGION, 2020–2026 (USD MILLION) 136
10.2 NORTH AMERICA 137
FIGURE 29 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET SNAPSHOT 137
TABLE 69 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 138
TABLE 70 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY COUNTRY, 2020–2026 (USD MILLION) 138
TABLE 71 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 138
TABLE 72 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020–2026 (USD MILLION) 139
TABLE 73 NORTH AMERICA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 139
TABLE 74 NORTH AMERICA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 139
TABLE 75 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2019 (USD MILLION) 140
TABLE 76 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2020–2026 (USD MILLION) 140
TABLE 77 NORTH AMERICA: IN VIVO TESTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 140
TABLE 78 NORTH AMERICA: IN VIVO TESTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 141
TABLE 79 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2016–2019 (USD MILLION) 141
TABLE 80 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2020–2026 (USD MILLION) 141
TABLE 81 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2016–2019 (USD MILLION) 142
TABLE 82 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2020–2026 (USD MILLION) 142
10.2.1 US 142
10.2.1.1 The economic burden associated with allergies is expected to drive the growth of the market 142
TABLE 83 US: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 143
TABLE 84 US: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2020–2026 (USD MILLION) 143
TABLE 85 US: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 143
TABLE 86 US: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 144
TABLE 87 US: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2019 (USD MILLION) 144
TABLE 88 US: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2020–2026 (USD MILLION) 144
TABLE 89 US: IN VIVO TESTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 145
TABLE 90 US: IN VIVO TESTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 145
TABLE 91 US: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2016–2019 (USD MILLION) 145
TABLE 92 US: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2020–2026 (USD MILLION) 146
TABLE 93 US: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2016–2019 (USD MILLION) 146
TABLE 94 US: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2020–2026 (USD MILLION) 146
10.2.2 CANADA 147
10.2.2.1 Rising funding activities in allergy diagnostics to drive the market growth in Canada 147
FIGURE 30 ALLERGIES, BY TYPE, POPULATION AGED 12 AND OLDER, CANADA (2017) 147
TABLE 95 CANADA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 148
TABLE 96 CANADA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2020–2026 (USD MILLION) 148
TABLE 97 CANADA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 148
TABLE 98 CANADA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 149
TABLE 99 CANADA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2019 (USD MILLION) 149
TABLE 100 CANADA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2020–2026 (USD MILLION) 149
TABLE 101 CANADA: IN VIVO TESTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 150
TABLE 102 CANADA: IN VIVO TESTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 150
TABLE 103 CANADA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2016–2019 (USD MILLION) 150
TABLE 104 CANADA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2020–2026 (USD MILLION) 151
TABLE 105 CANADA: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2016–2019 (USD MILLION) 151
TABLE 106 CANADA: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2020–2026 (USD MILLION) 151
10.3 EUROPE 152
TABLE 107 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 152
TABLE 108 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY REGION,
2020–2026 (USD MILLION) 152
TABLE 109 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 153
TABLE 110 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2020–2026 (USD MILLION) 153
TABLE 111 EUROPE: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 153
TABLE 112 EUROPE: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 154
TABLE 113 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2019 (USD MILLION) 154
TABLE 114 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2020–2026 (USD MILLION) 154
TABLE 115 EUROPE: IN VIVO TESTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 155
TABLE 116 EUROPE: IN VIVO TESTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 155
TABLE 117 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2016–2019 (USD MILLION) 155
TABLE 118 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2020–2026 (USD MILLION) 156
TABLE 119 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2016–2019 (USD MILLION) 156
TABLE 120 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2020–2026 (USD MILLION) 156
10.3.1 GERMANY 157
10.3.1.1 Germany accounted for the largest share of the EU market in 2020 157
TABLE 121 COMPARATIVE ANALYSIS OF ALLERGENS 157
TABLE 122 GERMANY: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 158
TABLE 123 GERMANY: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020–2026 (USD MILLION) 158
TABLE 124 GERMANY: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 158
TABLE 125 GERMANY: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 159
TABLE 126 GERMANY: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2019 (USD MILLION) 159
TABLE 127 GERMANY: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2020–2026 (USD MILLION) 159
TABLE 128 GERMANY: IN VIVO TESTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 160
TABLE 129 GERMANY: IN VIVO TESTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 160
TABLE 130 GERMANY: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2016–2019 (USD MILLION) 160
TABLE 131 GERMANY: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2020–2026 (USD MILLION) 161
TABLE 132 GERMANY: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2016–2019 (USD MILLION) 161
TABLE 133 GERMANY: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2020–2026 (USD MILLION) 161
10.3.2 UK 162
10.3.2.1 Increasing prevalence of food anaphylaxis in the UK to support the market growth 162
TABLE 134 UK: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 163
TABLE 135 UK: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2020–2026 (USD MILLION) 163
TABLE 136 UK: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 163
TABLE 137 UK: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 164
TABLE 138 UK: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2019 (USD MILLION) 164
TABLE 139 UK: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2020–2026 (USD MILLION) 164
TABLE 140 UK: IN VIVO TESTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 165
TABLE 141 UK: IN VIVO TESTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 165
TABLE 142 UK: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2016–2019 (USD MILLION) 165
TABLE 143 UK: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2020–2026 (USD MILLION) 166
TABLE 144 UK: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2016–2019 (USD MILLION) 166
TABLE 145 UK: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2020–2026 (USD MILLION) 166
10.3.3 FRANCE 167
10.3.3.1 Availability of reimbursements in France to support the growth of the market 167
TABLE 146 FRANCE: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 167
TABLE 147 FRANCE: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2020–2026 (USD MILLION) 167
TABLE 148 FRANCE: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 168
TABLE 149 FRANCE: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 168
TABLE 150 FRANCE: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2019 (USD MILLION) 168
TABLE 151 FRANCE: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2020–2026 (USD MILLION) 169
TABLE 152 FRANCE: IN VIVO TESTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 169
TABLE 153 FRANCE: IN VIVO TESTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 169
TABLE 154 FRANCE: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2016–2019 (USD MILLION) 170
TABLE 155 FRANCE: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2020–2026 (USD MILLION) 170
TABLE 156 FRANCE: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2016–2019 (USD MILLION) 170
TABLE 157 FRANCE: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2020–2026 (USD MILLION) 171
10.3.4 ITALY 171
10.3.4.1 Presence of allergy diagnostic organizations in Italy to support allergy diagnosis research & demand for products 171
TABLE 158 ITALY: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 171
TABLE 159 ITALY: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2020–2026 (USD MILLION) 172
TABLE 160 ITALY: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 172
TABLE 161 ITALY: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 172
TABLE 162 ITALY: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2019 (USD MILLION) 173
TABLE 163 ITALY: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2020–2026 (USD MILLION) 173
TABLE 164 ITALY: IN VIVO TESTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 173
TABLE 165 ITALY: IN VIVO TESTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 174
TABLE 166 ITALY: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2016–2019 (USD MILLION) 174
TABLE 167 ITALY: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2020–2026 (USD MILLION) 174
TABLE 168 ITALY: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2016–2019 (USD MILLION) 175
TABLE 169 ITALY: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2020–2026 (USD MILLION) 175
10.3.5 SPAIN 175
10.3.5.1 The government undertakes initiatives for the development of the healthcare system in Spain to support the market growth 175
TABLE 170 SPAIN: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 176
TABLE 171 SPAIN: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2020–2026 (USD MILLION) 176
TABLE 172 SPAIN: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 176
TABLE 173 SPAIN: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 177
TABLE 174 SPAIN: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2019 (USD MILLION) 177
TABLE 175 SPAIN: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2020–2026 (USD MILLION) 177
TABLE 176 SPAIN: IN VIVO TESTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 178
TABLE 177 SPAIN: IN VIVO TESTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 178
TABLE 178 SPAIN: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2016–2019 (USD MILLION) 178
TABLE 179 SPAIN: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2020–2026 (USD MILLION) 179
TABLE 180 SPAIN: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2016–2019 (USD MILLION) 179
TABLE 181 SPAIN: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2020–2026 (USD MILLION) 179
10.3.6 REST OF EUROPE (ROE) 180
TABLE 182 ROE: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 180
TABLE 183 ROE: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2020–2026 (USD MILLION) 180
TABLE 184 ROE: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 181
TABLE 185 ROE: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 181
TABLE 186 ROE: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2019 (USD MILLION) 181
TABLE 187 ROE: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2020–2026 (USD MILLION) 182
TABLE 188 ROE: IN VIVO TESTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 182
TABLE 189 ROE: IN VIVO TESTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 182
TABLE 190 ROE: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2016–2019 (USD MILLION) 183
TABLE 191 ROE: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2020–2026 (USD MILLION) 183
TABLE 192 ROE: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2016–2019 (USD MILLION) 183
TABLE 193 ROE: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2020–2026 (USD MILLION) 184
10.4 ASIA PACIFIC 184
FIGURE 31 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET SNAPSHOT 185
TABLE 194 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 186
TABLE 195 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY REGION,
2020–2026 (USD MILLION) 186
TABLE 196 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 186
TABLE 197 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020–2026 (USD MILLION) 187
TABLE 198 ASIA PACIFIC: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 187
TABLE 199 ASIA PACIFIC: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 187
TABLE 200 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2019 (USD MILLION) 188
TABLE 201 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2020–2026 (USD MILLION) 188
TABLE 202 ASIA PACIFIC: IN VIVO TESTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 188
TABLE 203 ASIA PACIFIC: IN VIVO TESTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 189
TABLE 204 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2016–2019 (USD MILLION) 189
TABLE 205 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2020–2026 (USD MILLION) 189
TABLE 206 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2016–2019 (USD MILLION) 190
TABLE 207 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2020–2026 (USD MILLION) 190
10.4.1 CHINA 190
10.4.1.1 China accounted for the largest share of the allergy diagnostics market in the Asia Pacific 190
TABLE 208 CHINA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 191
TABLE 209 CHINA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2020–2026 (USD MILLION) 191
TABLE 210 CHINA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 192
TABLE 211 CHINA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 192
TABLE 212 CHINA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2019 (USD MILLION) 192
TABLE 213 CHINA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2020–2026 (USD MILLION) 193
TABLE 214 CHINA: IN VIVO TESTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 193
TABLE 215 CHINA: IN VIVO TESTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 193
TABLE 216 CHINA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2016–2019 (USD MILLION) 194
TABLE 217 CHINA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2020–2026 (USD MILLION) 194
TABLE 218 CHINA: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2016–2019 (USD MILLION) 194
TABLE 219 CHINA: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2020–2026 (USD MILLION) 195
10.4.2 JAPAN 195
10.4.2.1 Increasing prevalence of allergies among children to propel the demand for allergy diagnostics in Japan 195
TABLE 220 JAPAN: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 196
TABLE 221 JAPAN: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2020–2026 (USD MILLION) 196
TABLE 222 JAPAN: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 196
TABLE 223 JAPAN: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 197
TABLE 224 JAPAN: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2019 (USD MILLION) 197
TABLE 225 JAPAN: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2020–2026 (USD MILLION) 197
TABLE 226 JAPAN: IN VIVO TESTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 198
TABLE 227 JAPAN: IN VIVO TESTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 198
TABLE 228 JAPAN: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2016–2019 (USD MILLION) 198
TABLE 229 JAPAN: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2020–2026 (USD MILLION) 199
TABLE 230 JAPAN: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2016–2019 (USD MILLION) 199
TABLE 231 JAPAN: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2020–2026 (USD MILLION) 199
10.4.3 INDIA 200
10.4.3.1 Limited awareness regarding allergy management to limit the growth of the market 200
TABLE 232 INDIA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 200
TABLE 233 INDIA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2020–2026 (USD MILLION) 201
TABLE 234 INDIA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 201
TABLE 235 INDIA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 201
TABLE 236 INDIA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2019 (USD MILLION) 202
TABLE 237 INDIA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2020–2026 (USD MILLION) 202
TABLE 238 INDIA: IN VIVO TESTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 202
TABLE 239 INDIA: IN VIVO TESTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 203
TABLE 240 INDIA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2016–2019 (USD MILLION) 203
TABLE 241 INDIA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2020–2026 (USD MILLION) 203
TABLE 242 INDIA: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2016–2019 (USD MILLION) 204
TABLE 243 INDIA: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2020–2026 (USD MILLION) 204
10.4.4 AUSTRALIA 204
10.4.4.1 High prevalence of food allergy to propel the growth of the allergy diagnostics market in Australia 204
TABLE 244 AUSTRALIA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 205
TABLE 245 AUSTRALIA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020–2026 (USD MILLION) 205
TABLE 246 AUSTRALIA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 206
TABLE 247 AUSTRALIA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 206
TABLE 248 AUSTRALIA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2019 (USD MILLION) 206
TABLE 249 AUSTRALIA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2020–2026 (USD MILLION) 207
TABLE 250 AUSTRALIA: IN VIVO TESTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 207
TABLE 251 AUSTRALIA: IN VIVO TESTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 207
TABLE 252 AUSTRALIA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2016–2019 (USD MILLION) 208
TABLE 253 AUSTRALIA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2020–2026 (USD MILLION) 208
TABLE 254 AUSTRALIA: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2016–2019 (USD MILLION) 208
TABLE 255 AUSTRALIA: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2020–2026 (USD MILLION) 209
10.4.5 REST OF ASIA PACIFIC 209
TABLE 256 ROAPAC: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 210
TABLE 257 ROAPAC: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2020–2026 (USD MILLION) 210
TABLE 258 ROAPAC: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2016–2019 (USD MILLION) 210
TABLE 259 ROAPAC: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 211
TABLE 260 ROAPAC: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2016–2019 (USD MILLION) 211
TABLE 261 ROAPAC: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,
2020–2026 (USD MILLION) 211
TABLE 262 ROAPAC: IN VIVO TESTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 212
TABLE 263 ROAPAC: IN VIVO TESTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 212
TABLE 264 ROAPAC: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2016–2019 (USD MILLION) 212
TABLE 265 ROAPAC: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,
2020–2026 (USD MILLION) 213
TABLE 266 ROAPAC: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2016–2019 (USD MILLION) 213
TABLE 267 ROAPAC: ALLERGY DIAGNOSTICS MARKET, BY END USER,
2020–2026 (USD MILLION) 213

10.5 LATIN AMERICA 214

TABLE 268 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY COUNTRY,

2016–2019 (USD MILLION) 214

TABLE 269 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY REGION,

2020–2026 (USD MILLION) 214

TABLE 270 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 215

TABLE 271 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2020–2026 (USD MILLION) 215

TABLE 272 LATIN AMERICA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 215

TABLE 273 LATIN AMERICA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 216

TABLE 274 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,

2016–2019 (USD MILLION) 216

TABLE 275 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,

2020–2026 (USD MILLION) 216

TABLE 276 LATIN AMERICA: IN VIVO TESTS MARKET, BY TYPE,

2016–2019 (USD MILLION) 217

TABLE 277 LATIN AMERICA: IN VIVO TESTS MARKET, BY TYPE,

2020–2026 (USD MILLION) 217

TABLE 278 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,

2016–2019 (USD MILLION) 217

TABLE 279 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,

2020–2026 (USD MILLION) 218

TABLE 280 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY END USER,

2016–2019 (USD MILLION) 218

TABLE 281 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY END USER,

2020–2026 (USD MILLION) 218

10.5.1 BRAZIL 219

10.5.1.1 Brazil accounted for the largest share of the allergy diagnostics market in Latin America 219

TABLE 282 BRAZIL: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,

2016–2019 (USD MILLION) 219

TABLE 283 BRAZIL: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,

2020–2026 (USD MILLION) 219

TABLE 284 BRAZIL: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,

2016–2019 (USD MILLION) 220

TABLE 285 BRAZIL: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,

2020–2026 (USD MILLION) 220

TABLE 286 BRAZIL: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,

2016–2019 (USD MILLION) 220

TABLE 287 BRAZIL: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,

2020–2026 (USD MILLION) 221

TABLE 288 BRAZIL: IN VIVO TESTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 221

TABLE 289 BRAZIL: IN VIVO TESTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 221

TABLE 290 BRAZIL: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,

2016–2019 (USD MILLION) 222

TABLE 291 BRAZIL: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,

2020–2026 (USD MILLION) 222

TABLE 292 BRAZIL: ALLERGY DIAGNOSTICS MARKET, BY END USER,

2016–2019 (USD MILLION) 222

TABLE 293 BRAZIL: ALLERGY DIAGNOSTICS MARKET, BY END USER,

2020–2026 (USD MILLION) 223

10.5.2 MEXICO 223

10.5.2.1 The availability of allergy education training to support the growth of the market in Mexico 223

TABLE 294 MEXICO: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,

2016–2019 (USD MILLION) 224

TABLE 295 MEXICO: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,

2020–2026 (USD MILLION) 224

TABLE 296 MEXICO: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,

2016–2019 (USD MILLION) 224

TABLE 297 MEXICO: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,

2020–2026 (USD MILLION) 225

TABLE 298 MEXICO: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,

2016–2019 (USD MILLION) 225

TABLE 299 MEXICO: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,

2020–2026 (USD MILLION) 225

TABLE 300 MEXICO: IN VIVO TESTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 226

TABLE 301 MEXICO: IN VIVO TESTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 226

TABLE 302 MEXICO: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,

2016–2019 (USD MILLION) 226

TABLE 303 MEXICO: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,

2020–2026 (USD MILLION) 227

TABLE 304 MEXICO: ALLERGY DIAGNOSTICS MARKET, BY END USER,

2016–2019 (USD MILLION) 227

TABLE 305 MEXICO: ALLERGY DIAGNOSTICS MARKET, BY END USER,

2020–2026 (USD MILLION) 227

10.5.3 REST OF LATIN AMERICA 228

10.5.3.1 The rising concentration of pollen in the environment is expected to propel the demand for allergy diagnostics in the region 228

TABLE 306 ROLATAM: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,

2016–2019 (USD MILLION) 228

TABLE 307 ROLATAM: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,

2020–2026 (USD MILLION) 228

TABLE 308 ROLATAM: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,

2016–2019 (USD MILLION) 229

TABLE 309 ROLATAM: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,

2020–2026 (USD MILLION) 229

TABLE 310 ROLATAM: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,

2016–2019 (USD MILLION) 229

TABLE 311 ROLATAM: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,

2020–2026 (USD MILLION) 230

TABLE 312 ROLATAM: IN VIVO TESTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 230

TABLE 313 ROLATAM: IN VIVO TESTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 230

TABLE 314 ROLATAM: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,

2016–2019 (USD MILLION) 231

TABLE 315 ROLATAM: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,

2020–2026 (USD MILLION) 231

TABLE 316 ROLATAM: ALLERGY DIAGNOSTICS MARKET, BY END USER,

2016–2019 (USD MILLION) 231

TABLE 317 ROLATAM: ALLERGY DIAGNOSTICS MARKET, BY END USER,

2020–2026 (USD MILLION) 232

10.6 MIDDLE EAST & AFRICA (MEA) 232

10.6.1 RISING INCIDENCES OF ALLERGY RHINITIS TO SUPPORT THE MARKET GROWTH IN THE MEA REGION 232

TABLE 318 MEA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,

2016–2019 (USD MILLION) 233

TABLE 319 MEA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,

2020–2026 (USD MILLION) 233

TABLE 320 MEA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,

2016–2019 (USD MILLION) 233

TABLE 321 MEA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE,

2020–2026 (USD MILLION) 234

TABLE 322 MEA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,

2016–2019 (USD MILLION) 234

TABLE 323 MEA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE,

2020–2026 (USD MILLION) 234

TABLE 324 MEA: IN VIVO TESTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 235

TABLE 325 MEA: IN VIVO TESTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 235

TABLE 326 MEA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,

2016–2019 (USD MILLION) 235

TABLE 327 MEA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN,

2020–2026 (USD MILLION) 236

TABLE 328 MEA: ALLERGY DIAGNOSTICS MARKET, BY END USER,

2016–2019 (USD MILLION) 236

TABLE 329 MEA: ALLERGY DIAGNOSTICS MARKET, BY END USER,

2020–2026 (USD MILLION) 236

11 COMPETITIVE LANDSCAPE 237

11.1 OVERVIEW 237

11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 237

11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN THE MARKET 237

11.3 REVENUE ANALYSIS 238

FIGURE 32 REVENUE ANALYSIS OF KEY PLAYERS IN THE ALLERGY DIAGNOSTICS MARKET 239

11.4 MARKET SHARE ANALYSIS 239

FIGURE 33 ALLERGY DIAGNOSTICS MARKET SHARE ANALYSIS (2020) 240

TABLE 330 ALLERGY DIAGNOSTICS MARKET: DEGREE OF COMPETITION 240

11.5 COMPANY EVALUATION QUADRANT (MAJOR PLAYERS) 241

11.5.1 STARS 241

11.5.2 EMERGING LEADERS 241

11.5.3 PERVASIVE PLAYERS 242

11.5.4 PARTICIPANTS 242

FIGURE 34 VENDOR DIVE: ALLERGY DIAGNOSTICS MARKET 242

11.6 COMPETITIVE LEADERSHIP MAPPING (START-UPS AND SMES) 243

11.6.1 PROGRESSIVE COMPANIES 243

11.6.2 STARTING BLOCKS 243

11.6.3 RESPONSIVE COMPANIES 243

11.6.4 DYNAMIC COMPANIES 243

FIGURE 35 ALLERGY DIAGNOSTICS MARKET: VENDOR DIVE MATRIX FOR SMES AND START-UPS, 2020 244

11.7 COMPANY FOOTPRINT 245

TABLE 331 COMPANY FOOTPRINT 245

TABLE 332 COMPANY PRODUCT & SERVICE FOOTPRINT 246

TABLE 333 COMPANY TEST TYPE FOOTPRINT 247

TABLE 334 COMPANY GEOGRAPHICAL FOOTPRINT 248

11.8 COMPETITIVE SCENARIO AND TRENDS 249

11.8.1 DEALS 249

TABLE 335 DEALS, JANUARY 2017-JULY 2021 249

11.8.2 PRODUCT LAUNCHES 250

TABLE 336 PRODUCT LAUNCHES, JANUARY 2017-JULY 2021 250

11.8.3 EXPANSIONS 251

TABLE 337 EXPANSIONS, JANUARY 2017-JULY 2021 251

11.8.4 OTHER DEVELOPMENTS 251

TABLE 338 OTHER DEVELOPMENTS, JANUARY 2017-JULY 2021 251

12 COMPANY PROFILES 252

12.1 KEY PLAYERS 252

(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win,

Strategic Choices Made, and Weaknesses and Competitive Threats))*

12.1.1 THERMO FISHER SCIENTIFIC INC. 252

TABLE 339 THERMO FISHER SCIENTIFIC INC. INC: BUSINESS OVERVIEW 252

FIGURE 36 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2020) 253

12.1.2 DANAHER 256

TABLE 340 DANAHER: BUSINESS OVERVIEW 256

FIGURE 37 DANAHER: COMPANY SNAPSHOT (2020) 257

12.1.3 MINARIS MEDICAL AMERICA, INC. 259

TABLE 341 MINARIS MEDICAL AMERICA, INC.: BUSINESS OVERVIEW 259

FIGURE 38 HITACHI CHEMICAL CO., LTD.: COMPANY SNAPSHOT (2019) 259

12.1.4 SIEMENS HEALTHINEERS AG 262

TABLE 342 SIEMENS HEALTHINEERS AG: BUSINESS OVERVIEW 262

FIGURE 39 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2020) 263

12.1.5 EUROFINS SCIENTIFIC 265

TABLE 343 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW 265

FIGURE 40 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2020) 266

12.1.6 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG 268

TABLE 344 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG: BUSINESS OVERVIEW 268

FIGURE 41 PERKINELMER: COMPANY SNAPSHOT (2020) 269

12.1.7 BIOMÉRIEUX SA 271

TABLE 345 BIOMÉRIEUX SA: BUSINESS OVERVIEW 271

FIGURE 42 BIOMÉRIEUX SA: COMPANY SNAPSHOT (2020) 272

12.1.8 STALLERGENES GREER LTD 273

TABLE 346 STALLERGENES GREER LTD.: BUSINESS OVERVIEW 273

12.1.9 ROMER LABS DIVISION HOLDING GMBH 274

TABLE 347 ROMER LABS DIVISION HOLDING GMBH: BUSINESS OVERVIEW 274

FIGURE 43 DSM ROYAL: COMPANY SNAPSHOT (2020) 275

12.1.10 NEOGEN CORPORATION 277

TABLE 348 NEOGEN CORPORATION: BUSINESS OVERVIEW 277

FIGURE 44 NEOGEN CORPORATION: COMPANY SNAPSHOT (2020) 278

12.1.11 HOLLISTERSTIER ALLERGY 280

TABLE 349 HOLLISTERSTIER ALLERGY: BUSINESS OVERVIEW 280

FIGURE 45 JUBILANT PHARMA LIMITED: COMPANY SNAPSHOT (2020) 281

12.1.12 OMEGA DIAGNOSTICS GROUP PLC 282

TABLE 350 OMEGA DIAGNOSTICS GROUP PLC : BUSINESS OVERVIEW 282

FIGURE 46 OMEGA DIAGNOSTICS GROUP PLC: COMPANY SNAPSHOT (2020) 283

12.2 OTHER PLAYERS 285

12.2.1 HOB BIOTECH GROUP CORP., LTD. 285

TABLE 351 HOB BIOTECH GROUP CORP., LTD.: BUSINESS OVERVIEW 285

12.2.2 HYCOR BIOMEDICAL 286

TABLE 352 HYCOR BIOMEDICAL: BUSINESS OVERVIEW 286

12.2.3 LINCOLN DIAGNOSTICS, INC. 287

TABLE 353 LINCOLN DIAGNOSTICS, INC.: BUSINESS OVERVIEW 287

12.2.4 R-BIOPHARM AG 288

TABLE 354 R-BIOPHARM AG: BUSINESS OVERVIEW 288

12.2.5 ASTRA BIOTECH GMBH 289

TABLE 355 ASTRA BIOTECH GMBH: BUSINESS OVERVIEW 289

12.2.6 ERBA GROUP 290

TABLE 356 ERBA GROUP: BUSINESS OVERVIEW 290

12.2.7 AESKU.GROUP GMBH 290

TABLE 357 AESKU.GROUP GMBH: BUSINESS OVERVIEW 290

12.2.8 ACON LABORATORIES, INC. 291

TABLE 358 ACON LABORATORIES, INC.: BUSINESS OVERVIEW 291

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX 292

13.1 INSIGHTS FROM INDUSTRY EXPERTS 292

13.2 DISCUSSION GUIDE 293

13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 298

13.4 AVAILABLE CUSTOMIZATIONS 300

13.5 RELATED REPORTS 300

13.6 AUTHOR DETAILS 301

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（アレルギー用薬）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（drug）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（アレルギー用薬）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（drug）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?